Program Manager Development Program
Archived on April 7, 2026. Sources Sought posted by HEALTH AND HUMAN SERVICES, DEPARTMENT OF (NATIONAL INSTITUTES OF HEALTH) on March 12, 2026. Solicitation 75N99226SS105.
NAICS 611430 (Professional and Management Development Training). Place of performance: Washington, District of Columbia. Original response deadline: . Full description on SAM.gov.
Description
The Advanced Research Projects Agency for Health (ARPA-H) is conducting market research in support of the Office of the Director (DIRO). ARPA-H has a requirement for a Program Manager Development Program to further the agency’s mission.
This requirement supports ARPA-H in executing its mission by enhancing Program Manager (PM) development, and implementation capability through an ARPA-H Program Manager Development Framework. This requirement is intended to deploy and sustain a fully operational Program Manager Development Framework by:
- Providing a day 1 fully deployable ready-to-use Program Manager Development Framework—requiring no additional stand‑up time—that is specifically designed to train and prepare Program Managers to operate effectively in an ARPA-like environment. The contractor shall demonstrate experience operating within an ARPA or similar high-risk, high-reward innovation culture to design, deliver, and refine the framework so that it rapidly builds and sustains program management, performer engagement, risk-mitigation, and transition-planning capabilities.
- Strengthening the capabilities of current ARPA-H PMs through structured mentorship, cross-PM learning, and targeted skill development that improves program design, metrics definition, risk management, and transition strategies.
This Sources Sought Notice serves to determine the capabilities of the market to provide specialized and agile solutions. Please see the attachment PMDP_SSN_031226 for further information that is being requested and instructions for responding to this notice.
Overview
Award Overview
Possible prior contracts
Sign in to see possible prior contracts for this requirement (matched by agency, NAICS and place of performance; not confirmed).
Contacts
Contracting Officer
Primary Contact
Documents
Showing 1 of 1 items
Document | Source | Agency | Posted Date | File Size | Actions | |
|---|---|---|---|---|---|---|
| Sources Sought | NATIONAL INSTITUTES OF HEALTH | Mar 12, 2026 | 223.98 KB |
Lifecycle
75N99226SS105- Market Research
Pre-solicitation or formal solicitation typically follows within 30–180 days. (estimate)
- Market ResearchCurrentMar 12, 2026
Program Manager Development Program
Similar Opportunities
Title | Phase | Agency | NAICS | Set Aside | Posted | Deadline | Location |
|---|---|---|---|---|---|---|---|
Amendment 0002 to Solicitation BARDA-27-100227, Device Development for Scientists Training, provides a revised RFQ and Performance Work Statement (PWS) and publishes the Government’s responses to questions. Quotations are due October 21, 2026, at 1:00 p.m. Eastern Time. The October 6, 2026, deadline for questions remains unchanged. AMENDMENT 0001 08 October 2026: The quote due date is extended to 1 pm ET on October 21, 2026, unless a further amendment is issued. Questions and answers will be posted to this notice. The RFQ and PWS will be revised and posted prior to the quote due date. Offerors should review the updated documents before submitting a quotation. See attached Amendment 0001. The objective of this requirement is to obtain a qualified Contractor to provide a two-day, in-person, instructor-led training course on Device Development for Scientists. The Government is finalizing the training dates, which will be stated in the revised RFQ and PWS. The training shall provide participants with an understanding of the scientific, clinical, regulatory, intellectual property, and commercial considerations involved in medical device development and bringing medical devices to market. | Solicitation | 611430 | Total Small Business Set-Aside | 10/14/2026 | 10/21/2026 | Washington, DC | |
AMENDMENT 0001 08 October 2026: The quote due date is extended to 1 pm ET on October 21, 2026, unless a further amendment is issued. Questions and answers will be posted to this notice. The RFQ and PWS will be revised and posted prior to the quote due date. Offerors should review the updated documents before submitting a quotation. See attached Amendment 0001. The objective of this requirement is to obtain a qualified Contractor to provide a two-day, in-person, instructor-led training course on Device Development for Scientists. The Government is finalizing the training dates, which will be stated in the revised RFQ and PWS. The training shall provide participants with an understanding of the scientific, clinical, regulatory, intellectual property, and commercial considerations involved in medical device development and bringing medical devices to market. | Solicitation | 611430 | Total Small Business Set-Aside | 10/08/2026 | 10/21/2026 | Washington, DC | |
Attached Sole Source Justification (SSJ) is being posted in accordance with RFO FAR 6.301(b) and RFO FAR 12.301(a). | Sole Source / J&A | 611430 | No Set-Aside | 10/06/2026 | Open | Washington, DC | |
The objective of this requirement is to obtain a qualified Contractor to provide a two-day, in-person, instructor-led training course on Device Development for Scientists. The Government’s preferred training dates are November 2–3, 2026, with flexibility for the training to be conducted on mutually agreed-upon dates in January 2027, if necessary The training shall provide participants with an understanding of the scientific, clinical, regulatory, intellectual property, and commercial considerations involved in medical device development and bringing medical devices to market | Solicitation | 611430 | Total Small Business Set-Aside | 10/05/2026 | 10/21/2026 | Washington, DC | |
The objective of this requirement is to obtain a qualified Contractor to provide a two-day, in-person, instructor-led training course on Device Development for Scientists. The Government’s preferred training dates are November 2–3, 2026, with flexibility for the training to be conducted on mutually agreed-upon dates in January 2027, if necessary The training shall provide participants with an understanding of the scientific, clinical, regulatory, intellectual property, and commercial considerations involved in medical device development and bringing medical devices to market | Solicitation | 611430 | Total Small Business Set-Aside | 10/02/2026 | 10/09/2026 | Washington, DC |
Additional Details
Solicitation Number
75N99226SS105
Archive Date
Apr 7, 2026
Office Address
Washington, DC, 20005